Table 1

Demographic information, laboratory information prior to the surgery and surgery duration in the AKI and non AKI groups
Parameter AKI No AKI Pa
Age (years) 3.7 ± 0.8, n = 12 4.1 ± 0.7, n = 26 0.749
Bodyweight (kg) 10.0 ± 2.0, n = 12 14 ± 2.4, n = 27 0.173
Admission BUN (mmol/L) 6.0 ± 0.85, n = 12 6.28 ± 0.43, n = 27 0.76
Surgery duration (h) 3.0 ± 0.8, n = 12 1.4 ± 0.1, n = 26 0.05
Admission Creatinine (μmol/L) 88.4 (53.0), n = 12 88.4 (26.5), n = 27 0.208
Gender (female) 58.3% (7/12) 70.4% (19/27) 0.486
Nephrotoxic drugs used b 50.0% (6/12) 40.7% (11/27) 0.590

Continuous data agreeing with a normal distribution are presented as means ± S.E.M., otherwise, the median (IQR) are presented; categorical data are reported as a percentage.

ap < 0.05 indicates a significant difference.

bNephrotoxic drugs used include NSAIDs, aminoglycoside antibiotics, ACE-inhibitors and chemotherapeutic medicine such as carboplatin.

Lee et al.

Lee et al. BMC Veterinary Research 2012 8:248   doi:10.1186/1746-6148-8-248

Open Data